# |
PMID |
Sentence |
1 |
10443587
|
N-methyl-D-aspartate (NMDA) subunits NR2A and NR2B, bind to the PSD protein called PSD-95, which in turn binds neuroligins, providing a handle for interacting with neurexin, located in the plasma membrane at the presynaptic active zone.
|
2 |
11908465
|
In contrast, 4 months after induction of diabetes NR2B subunit immunoreactivity, CaMKII and Tyr-dependent phosphorylation of the NR2A/B subunits of the NMDA receptor were reduced and alphaCaMKII autophosphorylation and its association to the NMDA receptor complex were impaired in STZ-rats compared with age-matched controls.
|
3 |
11908465
|
Insulin treatment prevented the reduction in kinase activities, NR2B expression levels, CaMKII-NMDA receptor association and NMDA currents.
|
4 |
12009768
|
Immunoblot analyses showed that levels of the N-methyl-d-aspartate (NMDA) subunits NR1 and NR2A were significantly decreased in neurons exposed to phenformin, whereas levels of the AMPA receptor subunit GluR1 were unchanged.
|
5 |
14754663
|
This study examined the effects of streptozotocin-diabetes and insulin or gliclazide treatment on the hippocampal NMDA receptor subunit 2A and 2B (NR2A and NR2B) concentrations.
|
6 |
14754663
|
Eight weeks after the induction of diabetes MDA, levels were increased, and NR2A and NR2B concentrations were reduced.
|
7 |
14754663
|
Insulin and gliclazide treatment partially prevented the reduction of NR2A and NR2B expression and prevented the elevation of MDA levels.
|
8 |
14754663
|
This study examined the effects of streptozotocin-diabetes and insulin or gliclazide treatment on the hippocampal NMDA receptor subunit 2A and 2B (NR2A and NR2B) concentrations.
|
9 |
14754663
|
Eight weeks after the induction of diabetes MDA, levels were increased, and NR2A and NR2B concentrations were reduced.
|
10 |
14754663
|
Insulin and gliclazide treatment partially prevented the reduction of NR2A and NR2B expression and prevented the elevation of MDA levels.
|
11 |
14754663
|
This study examined the effects of streptozotocin-diabetes and insulin or gliclazide treatment on the hippocampal NMDA receptor subunit 2A and 2B (NR2A and NR2B) concentrations.
|
12 |
14754663
|
Eight weeks after the induction of diabetes MDA, levels were increased, and NR2A and NR2B concentrations were reduced.
|
13 |
14754663
|
Insulin and gliclazide treatment partially prevented the reduction of NR2A and NR2B expression and prevented the elevation of MDA levels.
|
14 |
15370192
|
NR2A and NR2B protein concentrations were significantly decreased by about 30% in diabetic rats.
|
15 |
15370192
|
Dietary LC-PUFAs partially restored NR2A and NR2B in diabetic rats whereas the most significant increase was seen in nondiabetic rats.
|
16 |
15370192
|
NR2A and NR2B protein concentrations were significantly decreased by about 30% in diabetic rats.
|
17 |
15370192
|
Dietary LC-PUFAs partially restored NR2A and NR2B in diabetic rats whereas the most significant increase was seen in nondiabetic rats.
|
18 |
15893611
|
The levels of mRNAs coding for AMPA receptor subunits, GluR1, GluR2, and GluR3, were significantly increased in all layers (laminae I-V) of the dorsal horn in diabetic (STZ-injected) rats compared to control (vehicle-injected) rats.
|
19 |
15893611
|
The hybridization signals for NR2A mRNA and NR2B mRNA were significantly elevated in the deep layer of the dorsal horn of diabetic rats.
|
20 |
15893611
|
In diabetic (STZ-induced) rats, the levels of expression of mGluR1 mRNA and mGluR5 mRNA were significantly increased in all layers of the dorsal horn.
|
21 |
23603633
|
According to the different expression levels in the microarrays and their putative functions, six differentially expressed genes (LHCGR, ANGPTL1, TNIK, GRIN2A, SFRP4, and SOCS3) were selected and analyzed by quantitative RT-PCR (qRT-PCR).
|
22 |
23603633
|
Moreover, the molecular signatures (LHCGR, TNIK, and SOCS3) were associated with developmental potential from embryo to blastocyst stage and were proposed as biomarkers of embryo viability in PCOS patients.
|